📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

US investigating Meta for role in illicit drug sales, WSJ reports

Published 03/16/2024, 05:53 AM
Updated 03/16/2024, 07:00 AM
© Reuters. FILE PHOTO: People walk behind Meta Platforms logo during a conference in Mumbai, India, September 20, 2023. REUTERS/Francis Mascarenhas/File Photo
META
-

(Reuters) -U.S. prosecutors in Virginia are probing whether Facebook-parent Meta (NASDAQ:META)'s social media platforms facilitated and profited from the illegal sale of drugs, the Wall Street Journal reported on Saturday, citing documents and people familiar with the matter.

The prosecutors sent subpoenas last year and have been asking questions as part of a criminal grand jury probe, the report said, adding that they have also been requesting records related to drug content or illicit sale of drugs via Meta's platforms.

The Food and Drug Administration has also been helping with the investigation, the newspaper added. It noted that investigations do not always lead to charges of wrongdoing.

The paper quoted a spokesman for Meta as saying in a statement: “The sale of illicit drugs is against our policies and we work to find and remove this content from our services”.

“Meta proactively cooperates with law enforcement authorities to help combat the sale and distribution of illicit drugs,” he added.

The prosecutors’ office and a spokeswoman for the FDA declined to comment to WSJ.

© Reuters. FILE PHOTO: People walk behind Meta Platforms logo during a conference in Mumbai, India, September 20, 2023. REUTERS/Francis Mascarenhas/File Photo

Meta, the FDA and the Virginia Attorney General's office did not immediately respond to a Reuters' request for comment.

Meta's president of global affairs, Nick Clegg, said on social media platform X on Friday that Meta had joined up with the U.S. State Department, the United Nations Office on Drugs and Crime and Snapchat to help disrupt the sale of synthetic drugs online and educate users about the associated risks.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.